Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome in a patient with subacute cutaneous lupus (SCLE).

BMJ case reports - 4 Jan 2025

Tancer Stephanie, Rodgers Kyla, Fullen Douglas, Kahlenberg J Michelle

Abstract excerpt

A man in his 60s suffered from refractory, biopsy-proven subacute cutaneous lupus erythematosus that required chronic, moderate dose steroids to manage. His rash was accompanied by arthralgias and negative autoantibody testing. His subacute lupus erythematosus (SCLE) was responsive to tofacitinib, but thrombotic complications limited the use of this medication. He continued prednisone 20 mg daily to manage his...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Diseases, X-Linked
Share to Lupus Erythematosus, Cutaneous

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prednisone

Share to Syndrome

Share to Ubiquitin-Activating Enzymes

Share to Vacuoles

Source

Identifiers

PMID: 39755540
DOI: 10.1136/bcr-2024-261174

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome in a patient with subacute cutaneous lupus (SCLE).PMID 39755540Read ↗

An update on VEXAS syndrome.Semantic proximity Read ↗

VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.Semantic proximity Read ↗

VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies.Semantic proximity Read ↗

VEXAS syndrome: An update.Semantic proximity Read ↗

Case report: diagnosis of VEXAS syndrome in a patient with therapy-resistant large vessel vasculitis.Semantic proximity Read ↗

Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.Semantic proximity Read ↗

Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation.Semantic proximity Read ↗

VEXAS Syndrome—ReviewSemantic proximity Read ↗

VEXAS syndrome.Semantic proximity Read ↗

VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist.Semantic proximity Read ↗

VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations.Semantic proximity Read ↗

VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.